Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461641 · ClinicalTrials.gov registry record · NA
NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers
A NA study, sponsored by NuTech Medical.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT02461641: Completed NA study, sponsored by NuTech Medical.
NCT02461641 is a NA study that has completed, run by NuTech Medical. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02461641, a NA study, has completed, sponsored by NuTech Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study was designed to determine the heal rate of diabetic foot ulcers at 4 weeks, and complete closure at 8 and 12 weeks of patients treated with either NuShield or Affinity compared to standard care alone.
Primary Outcome
Percentage change in area method using ARANZ camera
Interventions
- OTHER Standard of Care
- OTHER NuShield
- OTHER Affinity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-10-25 |
| Phase | NA |
What the finished NCT02461641 record still lists
NCT02461641 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.
NCT02461641 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02461641 about?
NCT02461641 is a clinical study titled "NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers". This study was designed to determine the heal rate of diabetic foot ulcers at 4 weeks, and complete closure at 8 and 12 weeks of patients treated with either NuShield or Affinity compared to standard care alone.
What is the current status of trial NCT02461641?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2015-03. Estimated completion is 2018-10-25.
What interventions are being tested in trial NCT02461641?
The interventions under investigation include: Standard of Care (OTHER), NuShield (OTHER), Affinity (OTHER).
Who is sponsoring clinical trial NCT02461641?
This trial is sponsored by NuTech Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02461641's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia